Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices (vol 68, pg 1074, 2019)

被引：0
|
作者：
Bennett, Nancy [1 ]
Farley, Monica [2 ,3 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
[2] Vet Affairs Med Ctr, Decatur, GA 30033 USA
[3] Emory Univ, Dept Med, Atlanta, GA 30322 USA
来源：
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT | 2020年 / 68卷 / 51-52期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：1195 / 1195
页数：1
相关论文
共 50 条
  • [31] A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
    Ngamprasertchai, Thundon
    Kositamongkol, Chayanis
    Lawpoolsri, Saranath
    Rattanaumpawan, Pinyo
    Luvira, Viravarn
    Chongtrakool, Piriyaporn
    Kaewkungwal, Jaranit
    Chokephaibulkit, Kulkanya
    Phisalprapa, Pochamana
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [32] Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea
    Choi, Min-Joo
    Kang, Shin-On
    Oh, Jin-Jeong
    Park, Seong-Beom
    Kim, Min-Ja
    Cheong, Hee-Jin
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (08) : 1914 - 1922
  • [33] Response to Letter to the Editor regarding: Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 18-49 years of age, naive to 23-valent pneumococcal polysaccharide vaccine
    Bryant, Kristina
    Frenck, Robert W., Jr.
    VACCINE, 2016, 34 (38) : 4467 - 4467
  • [34] An Open-label Trial to Assess the Safety of 13-Valent Pneumococcal Conjugate Vaccine in Older Adults, Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine.
    Schwarz, T. F.
    Pauksens, K.
    Juergens, C.
    Jayawardene, D.
    Emini, E. A.
    Gruber, W. C.
    Scott, D. A.
    Schmoele-Thoma, B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S30 - S30
  • [35] Improved plasmablast response after repeated pneumococcal revaccinations following primary immunization with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine in patients with chronic lymphocytic leukemia
    Kattstrom, Magdalena
    Uggla, Bertil
    Tina, Elisabet
    Kimby, Eva
    Noren, Torbjorn
    Athlin, Simon
    VACCINE, 2023, 41 (19) : 3128 - 3136
  • [36] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis
    Vadlamudi, Nirma Khatri
    Parhar, Kamalpreet
    Malana, Kim Lorenzo Altre
    Kang, Amy
    Marra, Fawziah
    VACCINE, 2019, 37 (08) : 1021 - 1029
  • [37] The Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine versus 23-Valent Polysaccharide Vaccine in Adults Aged 50-80 Years
    Goldblatt, David
    Southern, Jo
    Andrews, Nick
    Ashton, Lindsey
    Burbidge, Polly
    Woodgate, Sarah
    Pebody, Richard
    Miller, Elizabeth
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (09) : 1318 - 1325
  • [38] Recommendations for the use of the 23-valent polysaccharide pneumococcal vaccine in adults: A Belgian consensus report
    Peetermans, WE
    Van de Vyver, N
    Van Laethem, Y
    Van Damme, P
    Thiry, N
    Trefois, P
    Geerts, P
    Schetgen, M
    Peleman, R
    Swennen, B
    Verhaegen, J
    ACTA CLINICA BELGICA, 2005, 60 (06) : 329 - 337
  • [39] Immunization status of the 23-valent pneumococcal polysaccharide vaccine among elderly aged 65 and older in South Korea
    Kim, Jeong Ah
    Won, Heehyun
    Jeong, Na-Young
    Choi, Nam-Kyong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 294 - 294
  • [40] Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
    Belmonti, Simone
    Rossetti, Barbara
    Modica, Sara
    Paglicci, Lorenzo
    Borghetti, Alberto
    Ciccullo, Arturo
    Picarelli, Chiara
    Cauda, Roberto
    De Luca, Andrea
    Montagnani, Francesca
    Lombardi, Francesca
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (03) : 453 - 462
12345